TARA US Equity
Protara Therapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1359931 · FY ends Dec 31
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 4.5M |
| % of shares out | 7.6% |
| Days to cover | 11.5 |
| Δ vs 2026-07-15 | -1.0% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 4,495,001 | -1.0% | 392,044 | 11.5 |
| 2026-07-15 | 4,541,891 | +4.8% | 676,262 | 6.7 |
| 2026-06-30 | 4,335,683 | -2.9% | 847,363 | 5.1 |
| 2026-06-15 | 4,465,466 | -24.2% | 682,189 | 6.5 |
| 2026-05-29 | 5,888,171 | +57.5% | 953,737 | 6.2 |
| 2026-05-15 | 3,739,353 | -37.6% | 665,961 | 5.6 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
